SK
Supria Kumari
About Supria Kumari
Data last updated:
Supria Kumari is a Director at Jurav Pharma Private Limited (since 2023) and Director at Jurav Health Point Private Limited (since 2021). The companies operate in Paper and Healthcare. The 2 current companies with reported revenue have a combined latest revenue of ₹33,177; the largest is Jurav Pharma Private Limited at ₹31,537 (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Jun 2023 | 2023 | ₹31,537 (FY 2025) | Active | |
| Director | 24 Jun 2021 | 2021 | ₹1,640 (FY 2025) | Active |
Board colleagues of Supria Kumari
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rakesh Kumar Singh | 07569226 | Jurav Pharma Private Limited | Director |
| Uday Kumar | 09215043 | Jurav Health Point Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Supria Kumari
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Supria Kumari
Supria Kumari currently holds 2 directorships: Jurav Pharma Private Limited (Director, since 13 Jun 2023, revenue ₹31,537 (FY 2025)); Jurav Health Point Private Limited (Director, since 24 Jun 2021, revenue ₹1,640 (FY 2025)).
Supria Kumari was first appointed on 24 Jun 2021 as Director at Jurav Health Point Private Limited. The most recent appointment on record is 13 Jun 2023 at Jurav Pharma Private Limited.
The 2 current companies of Supria Kumari that report revenue have a combined latest revenue of ₹33,177: Jurav Pharma Private Limited ₹31,537 (FY 2025); Jurav Health Point Private Limited ₹1,640 (FY 2025).
The current boards of Supria Kumari's companies include Rakesh Kumar Singh (Jurav Pharma Private Limited), Uday Kumar (Jurav Health Point Private Limited).